Polymer Capital Management’s AMN Healthcare AMN Stock Holding History

Polymer Capital Management’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,012	Closed	-$257K	–	630
2026 Q1	$257K	Buy	+14,012	New	+$266K	0.03%	670

Other funds holding AMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Polymer Capital Management's AMN Position: Q2 2026 in Review

Polymer Capital Management sold out of AMN Healthcare (AMN) in Q2 2026, closing a stake of 14,012 shares — an estimated $257K sold.

Polymer Capital Management first reported a position in AMN in Q1 2026 and held it in 1 quarter. The position peaked at $257K in Q1 2026. 286 funds tracked by Wall St. Rank hold AMN as of Q2 2026.

Polymer Capital Management reported no remaining AMN Healthcare position as of Q2 2026 after selling out during the quarter.
Polymer Capital Management sold 14,012 AMN Healthcare shares in Q2 2026, an estimated $257K.
Polymer Capital Management first reported a position in AMN Healthcare in Q1 2026 and held it in 1 quarter.
Polymer Capital Management's AMN Healthcare position peaked at $257K in Q1 2026.
286 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.